| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/20/1996 | CA2206400A1 Aromatic heterocyclic derivatives as enzyme inhibitors |
| 06/20/1996 | CA2183598A1 Treatment of toxoplasmosis |
| 06/20/1996 | CA2165517A1 Diamine ethylene derivative used in a cosmetic or dermatologic composition containing a compound with an irritating secondary effect |
| 06/20/1996 | CA2165374A1 Restricted 9-cis-retenoids |
| 06/20/1996 | CA2138474A1 Biodegradable injectable drug delivery polymer |
| 06/19/1996 | EP0717044A1 Thienopyridone derivatives, their preparation and their use as NMDA-receptor antagonists |
| 06/19/1996 | EP0717043A1 Use of 1,2-bridged 1,4-dihydropyridines as selective potassium channel modulators |
| 06/19/1996 | EP0717041A1 Crystalline paclitaxel hydrates |
| 06/19/1996 | EP0717040A1 Thiazine or thiazepine derivatives which inhibit NOS |
| 06/19/1996 | EP0717037A1 Substituted 1H-imidazoles having alpha 2-agonistic and alpha 1-antagonistic activity |
| 06/19/1996 | EP0717036A1 Use of 5-acyl-1,4-dihydropyridines for the treatment of diseases of the CNS |
| 06/19/1996 | EP0717034A1 Vitamin D compounds and method of preparing these compounds |
| 06/19/1996 | EP0717027A1 Diarylheptanoide derivative and pharmaceutical composition comprising the same |
| 06/19/1996 | EP0716857A1 Use of rapamycin for treating anemia |
| 06/19/1996 | EP0716856A2 Therapeutic uses of 2',5'-oligoadenylate derivatives |
| 06/19/1996 | EP0716855A2 Use of estrogen agonists for treating prostatic disease, obesity and bone loss |
| 06/19/1996 | EP0716854A2 Compositions for inhibiting neuropeptide y receptors |
| 06/19/1996 | EP0716853A1 Sustained release caffeine formulation |
| 06/19/1996 | EP0716852A1 Pharmaceutical formulations of cefaclor |
| 06/19/1996 | EP0716850A1 Use of an ethylene diamine derivative in a cosmetic or dermatological composition and in compositions containing materials with irritant side effects |
| 06/19/1996 | EP0716849A1 Cosmetic or dermatological composition containing a mixture of ceramides and its use for moisturizing the skin |
| 06/19/1996 | EP0716847A1 Cosmetic or dermatologic compositions containing cinnamic acid derivatives and a flavonoid |
| 06/19/1996 | EP0716693A1 Method and reagent for inhibiting human immunodeficiency virus replication |
| 06/19/1996 | EP0716661A1 Pseudo- and non-peptide bradykinin receptor antagonists |
| 06/19/1996 | EP0716657A1 ALKOXY-SUBSTITUTED $g(b)-CARBOLINES ACTING ON THE AMPA-RECEPTOR |
| 06/19/1996 | EP0716652A1 Carbocyclic and heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents |
| 06/19/1996 | EP0716650A1 Indole and indoline derivatives as 5ht1d receptor antagonists |
| 06/19/1996 | EP0716649A1 5-arylindole derivatives |
| 06/19/1996 | EP0716648A1 New 9-chloro-prostaglandin derivatives |
| 06/19/1996 | EP0716615A1 Low flux transdermal potent drug delivery system |
| 06/19/1996 | EP0716614A1 Treatment of human tumors by genetic transformation of human tumor cells |
| 06/19/1996 | EP0716607A1 Biochemically balanced peritoneal dialysis solutions |
| 06/19/1996 | EP0716606A1 Phosphate-binding polymers for oral administration |
| 06/19/1996 | EP0716605A1 Blocking the accumulation of germs on human cells |
| 06/19/1996 | EP0716603A1 Methods and compositions for inhibiting uridine secretion |
| 06/19/1996 | EP0716602A1 The primary and secondary neuroprotective effect of flupirtine in neurodegenerative diseases |
| 06/19/1996 | EP0716601A1 Use of thiol compounds in the therapy of viral diseases |
| 06/19/1996 | EP0716600A1 Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| 06/19/1996 | EP0716599A1 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE RELEASE OF 17-$g(b)-ESTRADIOL AND PROCESS FOR ITS PRODUCTION |
| 06/19/1996 | EP0716598A1 Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa |
| 06/19/1996 | EP0716596A1 New pharmaceutical compositions for topical use containing hyaluronic acid and its derivatives |
| 06/19/1996 | EP0716592A1 Compositions against skin impurities and mild forms of acne containing lanolinic acid or lanolinic acid components as active substance |
| 06/19/1996 | EP0605504B1 Cosmetic and dermatological preparations |
| 06/19/1996 | EP0578732B1 Chewable antacid compositions |
| 06/19/1996 | EP0577718B1 Use of sphingolipids in the preparation of a cosmetic or dermopharmaceutical composition protecting the skin and hair against the harmful effects of atmospheric pollution |
| 06/19/1996 | EP0571556B1 Non-antibacterial tetracycline compositions possessing antiplaque properties |
| 06/19/1996 | EP0535250B1 Novel compounds and use thereof as medicine |
| 06/19/1996 | EP0535192B1 Novel dna gyrase inhibitors, process for their manufacture and pharmaceutical preparations containing same |
| 06/19/1996 | EP0520024B1 Quinoxaline compounds and their preparation and use |
| 06/19/1996 | EP0516725B1 New use of linomide (r) |
| 06/19/1996 | EP0505452B1 Use of inositolphosphates for preparing medicament |
| 06/19/1996 | EP0381742B1 Receptor mediated endocytosis type mri contrast agents |
| 06/19/1996 | CN1124980A Modified oligonucleotides having improved anti-influenza activity |
| 06/19/1996 | CN1124961A Substituted pyrrolidin-3-Yl-alkyl-piperidines useful as tachykinin antagonists |
| 06/19/1996 | CN1124960A Indole derivatives as 5-HT1A and/or 5-HT2 ligands |
| 06/19/1996 | CN1124958A Triazole derivative or salt thereof, and fungicide containing the same |
| 06/19/1996 | CN1124957A 1-amidinophenyl-pyrrolidones piperidinones azetinones as platelet aggregation inhibitors |
| 06/19/1996 | CN1124953A Aromatic acetylcholinesterase inhibitors |
| 06/19/1996 | CN1124926A Pyrazolopyrimidinones for the treatment of impotence |
| 06/19/1996 | CN1124925A Lotion |
| 06/19/1996 | CN1124924A Ionene polymers as anthelmintics in animals |
| 06/19/1996 | CN1124923A Endothelin receptor antagonists |
| 06/19/1996 | CN1124922A Use of natural products and related synthetic compounds for the treatment of cardiovascular disease |
| 06/19/1996 | CN1124920A Oral compositions |
| 06/19/1996 | CN1124778A Antitumor antibiotic-Yunnan-mycin |
| 06/19/1996 | CN1124738A 7-glycosyloxybenzopyran derivative and antiallergic agent containing the derivative as active ingredient |
| 06/19/1996 | CN1124734A Thiazine- or thiazepine-derivatives |
| 06/19/1996 | CN1124731A Calcium complex of 4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9-triazaundecanedioic acid and is salts, pharmaceutical agents containing these complexes |
| 06/19/1996 | CN1124649A Compound preparation for resisting white diarrhea of poultry and domestic animals |
| 06/19/1996 | CN1124622A High-performance non-toxic vagina contraceptive |
| 06/19/1996 | CN1124621A Wettable powder of niclosamide salt |
| 06/19/1996 | CN1124620A Contraceptive |
| 06/19/1996 | CN1124618A Quick-acting cold oral liquid for child and preparing process thereof |
| 06/18/1996 | US5527945 Diphenylheteroalkyl derivatives, the preparation thereof and drugs and cosmetics prepared therefrom |
| 06/18/1996 | US5527940 Suppresses interleukin-1 and bone destruction during osteoporosis; antiinflammatory agents |
| 06/18/1996 | US5527924 Anticarcinogenic agents |
| 06/18/1996 | US5527919 Process for the preparation of 1-[(1,1'-biphenyl]-4-YL]-methyl-1H-imidazole-5-carboxylic acids |
| 06/18/1996 | US5527918 Processes for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl) biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid |
| 06/18/1996 | US5527910 Bactericides; staphylococcus, streptococcus infections |
| 06/18/1996 | US5527906 Acylation in solution of sodium bicarbonate in aqueous acetone with 2-/2-aminothiazol-4-yl/-2-syn-methoxyimino acetic acid-2-benzothiazolyl thioester |
| 06/18/1996 | US5527900 Viricides; anti-htlv activity |
| 06/18/1996 | US5527897 Genetic engineering |
| 06/18/1996 | US5527890 Derivatives of triterpenoid acids and uses thereof |
| 06/18/1996 | US5527884 Mediators of chronic allograft rejection and DNA molecules encoding them |
| 06/18/1996 | US5527832 Antiinflammatory and analgesic transdermal gel |
| 06/18/1996 | US5527831 Administering an ophthalmic solution of polyhyroxyalcohol such as sorbitol, mannitol, inositol or xylitol along with carrier to lower pressure |
| 06/18/1996 | US5527830 Drugs for the treatment of cardiac arrest and other shock states |
| 06/18/1996 | US5527829 HIV protease inhibitors |
| 06/18/1996 | US5527828 Spin trap nitronyl hindered phenols |
| 06/18/1996 | US5527827 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 06/18/1996 | US5527825 Administering hypodomaminergic agents, selected from nitro-l-arginine, n-imino ethyl-l-ornithine, l-canavanine and n-monomethyl-l-arginine |
| 06/18/1996 | US5527824 Substituted Di-T-Butlyphenols useful for inhibiting leukotriene synthesis |
| 06/18/1996 | US5527822 Administering butyrolactone derivatives |
| 06/18/1996 | US5527821 For treatment of urinary incontinence |
| 06/18/1996 | US5527817 N,n-dimethyl-2-(5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl) ethylamine; selective agonist of 5-ht1-like receptors; useful in treatment of migraines |
| 06/18/1996 | US5527814 Use of 2-amino-6-(trifluoromethoxy)benzothiazole for obtaining a medicament for the treatment of amyotrophic lateral sclerosis |
| 06/18/1996 | US5527809 Substituted imidazo[4,5-b]pyridines and benzimidazoles |
| 06/18/1996 | US5527808 Fused tricyclic nitrogen containing heterocycles |
| 06/18/1996 | US5527807 Treating alopecia, acne, prostate disorders |
| 06/18/1996 | US5527806 17α and 17β substituted acyl 4 aza steroids |